HKU COVID-19 vaccine trials to start in July
Share - WeChat

A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- Global Public Security Cooperation Forum to be held in Lianyungang
- Huangyan Island National Nature Reserve gets official go-ahead
- A capable assistant in classroom -- Chinese educators embrace AI
- China rolls out homegrown 9-valent HPV vaccine
- New coal-to-gas pipeline project begins in Xinjiang
- Horgos Port exports a record 214,000 vehicles in first 7 months of this year